BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12222753)

  • 1. Effect of cephalexin on the pharmacokinetics of metformin in healthy human volunteers.
    Jayasagar G; Krishna Kumar M; Chandrasekhar K; Madhusudan Rao C; Madhusudan Rao Y
    Drug Metabol Drug Interact; 2002; 19(1):41-8. PubMed ID: 12222753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of lansoprazole, an OCT inhibitor, on metformin pharmacokinetics in healthy subjects.
    Ding Y; Jia Y; Song Y; Lu C; Li Y; Chen M; Wang M; Wen A
    Eur J Clin Pharmacol; 2014 Feb; 70(2):141-6. PubMed ID: 24170325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A drug-drug interaction study to evaluate the impact of peficitinib on OCT1- and MATE1-mediated transport of metformin in healthy volunteers.
    Shibata M; Toyoshima J; Kaneko Y; Oda K; Nishimura T
    Eur J Clin Pharmacol; 2020 Aug; 76(8):1135-1141. PubMed ID: 32472157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N(1)-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin-trimethoprim interaction.
    Müller F; Pontones CA; Renner B; Mieth M; Hoier E; Auge D; Maas R; Zolk O; Fromm MF
    Eur J Clin Pharmacol; 2015 Jan; 71(1):85-94. PubMed ID: 25552403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and dose proportionality of extended-release metformin following administration of 1000, 1500, 2000 and 2500 mg in healthy volunteers.
    Cullen E; Liao J; Lukacsko P; Niecestro R; Friedhoff L
    Biopharm Drug Dispos; 2004 Sep; 25(6):261-3. PubMed ID: 15334625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of food on the pharmacokinetics of canagliflozin/metformin (150/1,000 mg) immediate-release fixed-dose combination tablet in healthy participants.
    Murphy J; Wang SS; Stieltjes H; Wajs E; Devineni D
    Int J Clin Pharmacol Ther; 2015 Mar; 53(3):256-64. PubMed ID: 25546166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics.
    Shu Y; Brown C; Castro RA; Shi RJ; Lin ET; Owen RP; Sheardown SA; Yue L; Burchard EG; Brett CM; Giacomini KM
    Clin Pharmacol Ther; 2008 Feb; 83(2):273-80. PubMed ID: 17609683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney function and age are both predictors of pharmacokinetics of metformin.
    Sambol NC; Chiang J; Lin ET; Goodman AM; Liu CY; Benet LZ; Cogan MG
    J Clin Pharmacol; 1995 Nov; 35(11):1094-102. PubMed ID: 8626883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of the ingestion of Ginkgo biloba extract (EGb 761) on the pharmacokinetics of metformin in non-diabetic and type 2 diabetic subjects--a double blind placebo-controlled, crossover study.
    Kudolo GB; Wang W; Javors M; Blodgett J
    Clin Nutr; 2006 Aug; 25(4):606-16. PubMed ID: 16698134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability and pharmacokinetics of metformin and the dipeptidyl peptidase-4 inhibitor sitagliptin when co-administered in patients with type 2 diabetes.
    Herman GA; Bergman A; Yi B; Kipnes M;
    Curr Med Res Opin; 2006 Oct; 22(10):1939-47. PubMed ID: 17022853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of food on the pharmacokinetics of gemigliptin/metformin sustained-release 50/1,000 mg (25/500 mg x 2 tablets) fixeddose combination tablet in healthy male volunteers.
    Choi HY; Noh YH; Kim YH; Kim MJ; Lee SH; Kim JA; Kim B; Lim HS; Bae KS
    Int J Clin Pharmacol Ther; 2014 May; 52(5):381-91. PubMed ID: 24495314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A dosing algorithm for metformin based on the relationships between exposure and renal clearance of metformin in patients with varying degrees of kidney function.
    Duong JK; Kroonen MYAM; Kumar SS; Heerspink HL; Kirkpatrick CM; Graham GG; Williams KM; Day RO
    Eur J Clin Pharmacol; 2017 Aug; 73(8):981-990. PubMed ID: 28451709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and bioequivalence evaluation of gliclazide/metformin combination tablet and equivalent doses of gliclazide and metformin in healthy Korean subjects.
    Cho HY; Yoon H; Lim YC; Lee YB
    Int J Clin Pharmacol Ther; 2009 Dec; 47(12):770-9. PubMed ID: 19954716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic comparison of a new glimepiride 1-mg + metformin 500-mg combination tablet formulation and a glimepiride 2-mg + metformin 500-mg combination tablet formulation: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy, fasting Korean male volunteers.
    Kim BH; Shin KH; Kim J; Lim KS; Kim KP; Kim JR; Cho JY; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Nov; 31(11):2755-64. PubMed ID: 20110017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of dipyridamole on the pharmacokinetics of metformin: a randomized crossover study in healthy volunteers.
    El Messaoudi S; Russel FG; Colbers A; Bandell CC; van den Broek PH; Burger DM; Rongen GA; Riksen NP
    Eur J Clin Pharmacol; 2016 Jun; 72(6):725-30. PubMed ID: 26979520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the pharmacokinetics of co-administered metformin and lobeglitazone, a thiazolidinedione antihyperglycemic agent, in healthy subjects.
    Shin D; Kim TE; Yoon SH; Cho JY; Shin SG; Jang IJ; Yu KS
    Curr Med Res Opin; 2012 Jul; 28(7):1213-20. PubMed ID: 22697273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effect of atenolol on urinary excretion of metformin via down-regulating multidrug and toxin extrusion protein 1 (rMate1) expression in the kidney of rats.
    Ma YR; Huang J; Shao YY; Ma K; Zhang GQ; Zhou Y; Zhi R; Qin HY; Wu XA
    Eur J Pharm Sci; 2015 Feb; 68():18-26. PubMed ID: 25486332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of canagliflozin on the pharmacokinetics of glyburide, metformin, and simvastatin in healthy participants.
    Devineni D; Manitpisitkul P; Murphy J; Skee D; Wajs E; Mamidi RN; Tian H; Vandebosch A; Wang SS; Verhaeghe T; Stieltjes H; Usiskin K
    Clin Pharmacol Drug Dev; 2015; 4(3):226-36. PubMed ID: 27140803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of the pharmacokinetic interactions of the direct renin inhibitor aliskiren with metformin, pioglitazone and fenofibrate in healthy subjects.
    Vaidyanathan S; Maboudian M; Warren V; Yeh CM; Dieterich HA; Howard D; Dole WP
    Curr Med Res Opin; 2008 Aug; 24(8):2313-26. PubMed ID: 18786303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitation of metformin in human plasma and urine by hydrophilic interaction liquid chromatography and application to a pharmacokinetic study.
    Nielsen F; Christensen MM; Brøsen K
    Ther Drug Monit; 2014 Apr; 36(2):211-7. PubMed ID: 24097013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.